Zobrazeno 1 - 10
of 2 807
pro vyhledávání: '"inflammatory bowel disease (ibd)"'
Publikováno v:
JEADV Clinical Practice, Vol 3, Iss 4, Pp 1102-1108 (2024)
Abstract Background Skin cancer is the most common form of cancer in Ireland with over 13,000 new cases diagnosed annually. People with inflammatory bowel disease are at higher risk of developing skin cancer. Objectives The aim of this study is to as
Externí odkaz:
https://doaj.org/article/b7f8fd9773b64170a8887c465e8eb47a
Publikováno v:
Biological Procedures Online, Vol 26, Iss 1, Pp 1-19 (2024)
Abstract To explore the effects and mechanisms of the Xianhecao-Huanglian drug pair on autophagy-mediated intervention in acute inflammatory bowel disease (IBD) via the JAK2/STAT3 pathway. The study examined the underlying mechanisms of action of Xia
Externí odkaz:
https://doaj.org/article/7ce71fc06adf48a4bacccbd27eea4dff
Publikováno v:
Gastroenterology Insights, Vol 15, Iss 3, Pp 647-660 (2024)
The consequences of inflammatory bowel disease (IBD) in children are connected to possible detrimental impacts on growth, development, psychosocial function, and general well-being. Therefore, the primary management plan in pediatric IBD is to achiev
Externí odkaz:
https://doaj.org/article/edcaf417c4404228a2ab9276215a6048
Publikováno v:
Shanghai Jiaotong Daxue xuebao. Yixue ban, Vol 44, Iss 7, Pp 839-846 (2024)
It is estimated that approximately seven million people worldwide are affected by inflammatory bowel disease (IBD), causing a huge burden on healthcare systems and society. In the occurrence, progression, and treatment of IBD, the intestinal microbio
Externí odkaz:
https://doaj.org/article/51b45f18d53245809aed2a82e4bc5dc4
Publikováno v:
Applied Medical Informatics, Vol 46, Iss 2, Pp 37-45 (2024)
Introduction: Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), pose significant challenges to both clinicians and researchers. The complex interaction of genetic predisposition, environmental influences,
Externí odkaz:
https://doaj.org/article/a3167b5cd402465cb2ed1e4590d3e0a5
Publikováno v:
Gastroenterology Insights, Vol 15, Iss 2, Pp 471-485 (2024)
The process of development, recurrence, and exacerbation of the inflammatory process depends on the cytokine levels in IBD. For that reason, many cytokine therapies have been developed for treating IBD patients. Researchers employ various techniques
Externí odkaz:
https://doaj.org/article/e866b9d6edff461db8e3a1ad7bd5cded
Autor:
Na Li, Cheng Zhao, Pingnan Zhang, Songting Wu, Xiaotan Dou, Saifei Xu, Xiaoqi Zhang, Chunyan Peng, Ying Xie, Shuling Huang, Lin Zhou, Yonghua Shen, Lei Wang, Jinglin Wang, Chenggong Yu
Publikováno v:
Engineered Regeneration, Vol 5, Iss 2, Pp 228-246 (2024)
The gut has been a focal point in the research of digestive system disorders. The internal microbiota generates metabolites that function as signaling molecules and substrates, interacting with the intestinal wall and influencing host physiology and
Externí odkaz:
https://doaj.org/article/8a4748be5b5943be9e98c1f29589527f
Publikováno v:
Health Science Reports, Vol 7, Iss 10, Pp n/a-n/a (2024)
Abstract Background and Aims The coronavirus disease 2019 (COVID‐19) pandemic has affected the management of inflammatory bowel disease (IBD) patients. Elective operations and surveillance endoscopies were postponed for IBD patients to preserve hea
Externí odkaz:
https://doaj.org/article/30bf30191e9c434191687581429b0126
Autor:
Sotaro Ozaka, Akira Sonoda, Yoko Kudo, Kanako Ito, Naganori Kamiyama, Nozomi Sachi, Thanyakorn Chalalai, Yomei Kagoshima, Yasuhiro Soga, Supanuch Ekronarongchai, Shimpei Ariki, Kazuhiro Mizukami, Shiori Ishizawa, Mitsue Nishiyama, Kazunari Murakami, Kiyoshi Takeda, Takashi Kobayashi
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundInflammatory bowel disease (IBD) is a refractory inflammatory disorder of the intestine, which is probably triggered by dysfunction of the intestinal epithelial barrier. Secretory leukocyte protease inhibitor (SLPI) secreted by colon epithe
Externí odkaz:
https://doaj.org/article/08c9e20a3b4f45b4b6edb22f252cb641
Autor:
Enze Fu, Meng Qian, Ningning He, Yilun Yin, Yue Liu, Zhibo Han, ZhongChao Han, Qiang Zhao, Xiaocang Cao, Zongjin Li
Publikováno v:
Advanced Science, Vol 11, Iss 36, Pp n/a-n/a (2024)
Abstract The management of dysfunctional intestinal epithelium by promoting mucosal healing and modulating the gut microbiota represents a novel therapeutic strategy for inflammatory bowel disease (IBD). As a convenient and well‐tolerated method of
Externí odkaz:
https://doaj.org/article/98aaf7c66cf64b979b4011562c6ea74d